Who owns DepoMed?

Key details on DepoMed (Ticker: DEPO)

Who owns DepoMed?

Is DEPO a good stock to own? Find out who bought DepoMed, who sold DepoMed (DEPO) stock, and who holds a large position in DepoMed.

Fund Name Number of Shares Share Valuation As Of
Broadfin Capital 4.74M $50.20M Dec. 31, 2013
Rima Management 4.47M $64.82M March 31, 2014
Inves 2.94M $42.65M March 31, 2014
BlackRock Fund Advisors 2.70M $39.13M March 31, 2014
NorthPointe Capital 2.68M $15.74M March 31, 2013
Deltec Asset Management 2.54M $36.77M March 31, 2014
Millennium Management 2.28M $33.05M March 31, 2014
BlackRock Institutional Trust Company, N.A. 1.98M $28.78M March 31, 2014
Vanguard 1.97M $28.60M March 31, 2014
STATE STREET CORPORATION 1.89M $27.35M March 31, 2014
S.A.C. Capital Advisors 1.87M $19.76M Dec. 31, 2013
VHCP Management 1.47M $7.62M Dec. 31, 2011
Deerfield Management Company 1.26M $13.34M Dec. 31, 2013
Schroder Investment Management 1.26M $7.86M March 31, 2012
Park West Asset Management 1.21M $9.04M Sept. 30, 2013
FMR 1.04M $15.11M March 31, 2014
D. E. Shaw & Co 945957 $13.72M March 31, 2014
Consonance Capital 899405 $5.28M March 31, 2013
Tang Capital Management 835931 $6.24M Sept. 30, 2013
NORTHERN TRUST 793219 $11.50M March 31, 2014
GOLDMAN SACHS 750934 $7.94M Dec. 31, 2013
Perimeter Capital Partners 691571 $4.28M Dec. 31, 2012
Emerald Advisers 689734 $10.00M March 31, 2014
T. Rowe Price Associates 677900 $5.07M Sept. 30, 2013
Century Capital Management 653639 $9.48M March 31, 2014
Technical Financial Services 647893 $3.64M June 30, 2013
Acadian Asset Management 633413 $8.80M June 30, 2014
J. Goldman & Co 606900 $4.53M Sept. 30, 2013
Renaissance Technologies 602608 $3.12M Dec. 31, 2011
Emerald Mutual Fund Advisers, Trust 592607 $8.59M March 31, 2014
Perceptive Advisors 550000 $3.25M Sept. 30, 2012
Charles Schwab Bank 546204 $93.05M March 31, 2013
BOGLE INVESTMENT MANAGEMENT L P /DE/ 510720 $7.41M March 31, 2014
Allianz Asset Management AG 500801 $7.26M March 31, 2014
NUMERIC INVESTORS 498377 $3.12M March 31, 2012
AQR Capital Management 484500 $7.03M March 31, 2014

Who sold DepoMed?

Fund Name Date Sold Number of Shares Sold Share Valuation
Third Point June 30, 2011 2.03M $16.61M
Barclays March 31, 2011 719500 $7.22M
Next Century Growth Investors March 31, 2011 660186 $6.63M
Highline Capital Management Dec. 31, 2010 695500 $4.42M